EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Tempol Mitigates Methotrexate-Induced Osteotoxicity via Oxidative Stress Modulation and MAPK Pathway Inhibition

Fariz Selimli, Meryem Taş Reyhanioğlu, Ahmet Can Haskan, Muhammed Said Altun, Soner Mete, Halil Mahir Kaplan iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s510206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Fariz Selimli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Mustafa Kemal University, Hatay, Turkey. Hauptthemen laut MEDLINE: Methotrexate, Cyclic N-Oxides, Oxidative Stress, MAP Kinase Signaling System. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateCyclic N-OxidesOxidative StressMAP Kinase Signaling SystemAntioxidantsOsteocytesSpin LabelsApoptosisAnimalsMiceDose-Response Relationship, DrugCell SurvivalStructure-Activity RelationshipCells, CulturedCell Line

Stichwörter der Autor:innen

methotrexateosteotoxicityoxidative stress and MAPKtempol

Substanzen

MethotrexateSpin LabelsCyclic N-OxidestempolAntioxidants

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Mustafa Kemal University, Hatay, Turkey.
  • Department of Medical Services and Techniques, Medical Promotion and Marketing Program, Medical Vocational Higher Services School, Nevsehir Haci Bektas University, Nevşehir, Turkey.
  • Deparment of Medicinal Pharmacology, Faculty of Medicine, Cukurova University, Adana, Turkey.

ORCID-Profile: Halil Mahir Kaplan

Zitieren

APA

Selimli, F., Taş Reyhanioğlu, M., Haskan, A. C., Altun, M. S., Mete, S., & Kaplan, H. M. (2025). Tempol Mitigates Methotrexate-Induced Osteotoxicity via Oxidative Stress Modulation and MAPK Pathway Inhibition. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s510206

Vancouver

Selimli F, Taş Reyhanioğlu M, Haskan AC, Altun MS, Mete S, Kaplan HM. Tempol Mitigates Methotrexate-Induced Osteotoxicity via Oxidative Stress Modulation and MAPK Pathway Inhibition. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s510206

BibTeX
@article{Selimli2025,
  author = {Selimli, Fariz and Taş Reyhanioğlu, Meryem and Haskan, Ahmet Can and Altun, Muhammed Said and Mete, Soner and Kaplan, Halil Mahir},
  title = {Tempol Mitigates Methotrexate-Induced Osteotoxicity via Oxidative Stress Modulation and MAPK Pathway Inhibition},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s510206}
}
Kostenlos starten →